Loading
Astrana Health, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp, was filed 17 Jun 2022.
Insider Decl.
412
Thresholds
n/a
Buy Volume
€24M
59 ops. · all time
Sell Volume
€62M
58 ops. · all time
Since the insiders bought
- -14.5%Entry US$36.97 · Close at T+365 US$31.61
- -1.8%Entry US$33.08 · Close at T+365 US$32.47
- +450.1%Entry US$17.30 · Close at T+365 US$95.16
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Astrana Health, Inc. Strong Buy (bullish), based on 9 analysts. Average price target: US$51.67.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 20,044 of 26,248 companies
33.4
score / 100
Value42
Quality25
FCF yld5.5%
Earn yld1.2%
EV/EBITDA22.1x
ROE6.9%
Gross mgn11%
Net mgn0.7%
Debt/EBITDA8.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$38.58
Analyst consensus
9 analystsStrong buy
US$41.00Target US$51.67(+34%)US$65.00
Income statement
RevenueUS$3.2B
Gross profitUS$341.5M11% margin
EBITDAUS$135.3M4% margin
Net incomeUS$22.5M1.1% margin
Valuation
PER (trailing)44.3x
PER (forward)10.6x
P/Book2.3x
Beta1.03
Balance sheet & cash
Market capUS$1.9B
Total debtUS$1.1B
Free Cash FlowUS$104.5M
Debt / Equity164%
Profitability & ownership
ROE6.9%
ROA3.8%
% insiders22.8%
% institutions66.7%
Last declaration on 13 October 2026
Declarations412 total
556 shares@ US$37.550.0011% mcap20.0% of flowCommon StockSEC:0001104659-26-115507:0
2,624 shares@ US$37.000.0053% mcap6.0% of flowCommon StockSEC:0001104659-26-114777:0
9,889 shares@ US$37.000.020% mcap12.6% of flowCommon StockSEC:0001104659-26-114785:0
2,092 shares@ US$35.880.0042% mcap5.3% of flowCommon StockSEC:0001104659-26-113838:0
96 shares@ US$38.350.0002% mcap3.4% of flowCommon StockSEC:0001104659-26-108627:0
7,163 shares@ US$38.470.014% mcap4.1% of flowCommon StockSEC:0001104659-26-106325:0
1,790 shares@ US$38.470.0035% mcap3.5% of flowCommon StockSEC:0001104659-26-105932:0
8,500 shares@ US$37.090.019% mcap25.5% of flowCommon StockSEC:0001104659-26-104397:0
20,000 shares@ US$5.000.0060% mcap6.6% of flowCommon StockSEC:0001104659-26-098353:0
20,000 shares@ US$38.590.046% mcap50.6% of flowCommon StockSEC:0001104659-26-098353:1
11,793 shares0Common StockSEC:0001104659-26-094142:0
1,093 sharesCommon StockSEC:0001104659-26-079333:0
4,525 sharesCommon StockSEC:0001104659-26-073467:0
4,525 sharesCommon StockSEC:0001104659-26-073475:0
4,525 sharesCommon StockSEC:0001104659-26-073484:0
4,991 sharesCommon StockSEC:0001104659-26-073485:0
4,525 sharesCommon StockSEC:0001104659-26-073488:0
4,525 sharesCommon StockSEC:0001104659-26-073493:0
3,870 shares@ US$29.070.0058% mcap7.9% of flowCommon StockSEC:0001104659-26-043808:0
201,056 shares0Common StockSEC:0001104659-26-040951:0
100,000 shares0Common StockSEC:0001104659-26-040952:0
41,667 shares0Common StockSEC:0001104659-26-040955:0
35,300 shares0Common StockSEC:0001104659-26-039688:0
2,092 shares@ US$25.053.8% of flowCommon StockSEC:0001104659-26-039686:0
57,980 shares@ US$24.5155.8% of flowCommon StockSEC:0001104659-26-039688:1
25 of 412 declarations
About Astrana Health, Inc.
Allied Physicians of California appears on both sides of the trades at Astrana Health, Inc.: the largest sale, EUR 34,068,144 on April 1, 2021, carries its signature, and its purchases reach EUR 8,770,387 on June 17, 2022, EUR 2,516,538 on August 17, 2021 and EUR 2,018,800 on April 28, 2021. Linda Marsh (Director) sold EUR 8,770,387 on June 17, 2022 and David Schmidt (Director) EUR 2,516,538 on August 17, 2021. In all, 63 purchases worth EUR 24,148,899 (median EUR 77,583) and 58 sales worth EUR 62,423,481 (median EUR 208,327), so purchases are 52%.
For 63 purchases, stored past results show a median 90-day return of 0.6%, positive in 52% of cases (stored results, not a forecast). From June 11 to June 14, 2019, five filers bought EUR 331,491.
Read moreShow less
This US healthcare company, valued at USD 1.9 billion and 22.8% held by its insiders, has 412 filings from May 18, 2016 to October 13, 2026. Yearly volume rises to 73 in 2019. Warren Hosseinion (Co-Chief Executive Officer) has 36 sales among 39 filings. The last twelve months hold 41 filings, with neither purchase nor sale.
